INSP inspiresleep.com Market Cap to Net Assets Ratio

Official company branding of Inspire Medical (INSP)

The price history on the Inspire Medical Systems (INSP) chart reflects the dynamics of a company that develops implantable anti-snoring devices, ensuring multi-year recurring revenue from client maintenance. The current metric stands at 2.48. The firm maintains its leadership in therapy through investments in smart, minimally invasive developments. High demand for exclusive solutions enables the company to exercise pricing power by setting premium rates, which are covered by US insurers.

INSP Inspire Medical Systems Inc: Market Value to Book Value in the range 07/04/2022 - 10/27/2026
Original product of Inspire Medical

Inspire Medical Systems (INSP) is scaling the sleep stimulator market through the aggressive hiring of elite sales managers and the training of surgeons, creating significant intangible business value. By analyzing the price-to-book ratio, an investor can see the market premium over net assets: the higher the coefficient, the more the market values intellectual capital and growth potential relative to the company's physical assets.

Competitor analysis

Market Value to Book Value Ratio DexCom, Inc. (DXCM)|Market Capitalization to Net Assets penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|PROCEPT BioRobotics Inc (PRCT) - Market Capitalization to Book Value Ratio|Market Value to Book Value CONMED Inc. (CNMD)|PLSE: Market Capitalization to Book Value Ratio|inmodemd.com - Market-to-Book Ratio|Market Value to Book Value Ratio Picard Medical (PMI)|SRDX - Market Value to Book Value|SENS: Market Capitalization to Book Value Ratio|NPCE (NeuroPace Medical) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Tactile Systems Technology, Inc. TCMD|Market Capitalization to Net Assets sanuwave.com|Outset Medical - Market Capitalization to Book Value Ratio|Market-to-Book Ratio smartvest.com ELMD|Market Cap to Net Assets Ratio LNSR (LENSAR, Inc)|RCEL - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Profound Medical Corporation PROF|BDMD - Market Cap to Book Value Multiple|edap-tms.com - Market Capitalization to Book Value Ratio|Apyx Medical Corporation (APYX) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ICCM|Market Cap to Net Assets Ratio Pulmonx Corp. (LUNG)|TELA Bio, Inc. (TELA) - Market Cap to Net Assets Ratio|Market Value to Book Value CTSO (cytosorbents.com)|Sensus Healthcare - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Zynex Medical ZYXI|ECOR (electroCore Medical) - Market Capitalization to Book Value Ratio|RBOT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio inspira-technologies.com|seastarmedical.com (ICU) - Capitalization to Book Value Ratio|IRIX: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Intelligent Bio|Market Capitalization to Book Value Ratio XAIR (Beyond Air, Inc.)|Market Cap to Net Assets Ratio Profusa, Inc (PFSA)|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Market Capitalization to Book Value Ratio|NAOV - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)